Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
Int. braz. j. urol
;
46(supl.1): 125-132, July 2020. tab
Article
Dans Anglais
| LILACS
| ID: biblio-1134278
ABSTRACT
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Pneumopathie virale
/
Infections à coronavirus
/
Recherche biomédicale
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Int. braz. j. urol
Thème du journal:
Urologie
Année:
2020
Type:
Article
Pays d'affiliation:
Espagne
Institution/Pays d'affiliation:
IIS-Fundación Jiménez Díaz - ISCIII-CIBERES/ES
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS